These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6241211)

  • 21. Pituitary-adrenocortical hyperfunction and intolerance to fluvoxamine, a selective serotonin uptake inhibitor.
    Brown WA; Arato M; Shrivastava R
    Am J Psychiatry; 1986 Jan; 143(1):88-90. PubMed ID: 3079969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A comparison of paroxetine, imipramine and placebo in depressed out-patients.
    Dunbar GC; Cohn JB; Fabre LF; Feighner JP; Fieve RR; Mendels J; Shrivastava RK
    Br J Psychiatry; 1991 Sep; 159():394-8. PubMed ID: 1835664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular effects of imipramine, fluvoxamine, and placebo in depressed outpatients.
    Laird LK; Lydiard RB; Morton WA; Steele TE; Kellner C; Thompson NM; Ballenger JC
    J Clin Psychiatry; 1993 Jun; 54(6):224-8. PubMed ID: 8331091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical pharmacology of bupropion and imipramine in elderly depressives.
    Branconnier RJ; Cole JO; Ghazvinian S; Spera KF; Oxenkrug GF; Bass JL
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):130-3. PubMed ID: 6406441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antidepressant efficacy in relation to item analysis and severity of depression: a placebo-controlled trial of fluvoxamine versus imipramine.
    Kasper S; Möller HJ; Montgomery SA; Zondag E
    Int Clin Psychopharmacol; 1995 Jan; 9 Suppl 4():3-12. PubMed ID: 7622821
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical trials of fluvoxamine vs chlorimipramine with single and three times daily dosing.
    De Wilde JE; Mertens C; Wakelin JS
    Br J Clin Pharmacol; 1983; 15 Suppl 3(Suppl 3):427S-431S. PubMed ID: 6407503
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluvoxamine and chlorimipramine in endogenous depression.
    De Wilde JE; Doogan DP
    J Affect Disord; 1982 Sep; 4(3):249-59. PubMed ID: 6215443
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A 6-week, double-blind trial of paroxetine, imipramine, and placebo in depressed outpatients.
    Fabre LF
    J Clin Psychiatry; 1992 Feb; 53 Suppl():40-3. PubMed ID: 1531823
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rolipram in major depressive disorder: results of a double-blind comparative study with imipramine.
    Hebenstreit GF; Fellerer K; Fichte K; Fischer G; Geyer N; Meya U; Sastre-y-Hernández M; Schöny W; Schratzer M; Soukop W
    Pharmacopsychiatry; 1989 Jul; 22(4):156-60. PubMed ID: 2668980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo.
    Cassano GB; Conti L; Massimetti G; Mengali F; Waekelin JS; Levine J
    Psychopharmacol Bull; 1986; 22(1):52-8. PubMed ID: 3088668
    [No Abstract]   [Full Text] [Related]  

  • 31. A double-blind comparison of fluoxetine, imipramine and placebo in outpatients with major depression.
    Feighner JP; Boyer WF; Merideth CH; Hendrickson GG
    Int Clin Psychopharmacol; 1989 Apr; 4(2):127-34. PubMed ID: 2663975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A placebo- and imipramine-controlled study of paroxetine.
    Cohn JB; Crowder JE; Wilcox CS; Ryan PJ
    Psychopharmacol Bull; 1990; 26(2):185-9. PubMed ID: 2146697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A double-blind, randomized comparison of fluvoxamine with mianserin in depressive illness.
    Perez A; Ashford JJ
    Curr Med Res Opin; 1990; 12(4):234-41. PubMed ID: 2127561
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluvoxamine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness.
    Benfield P; Ward A
    Drugs; 1986 Oct; 32(4):313-34. PubMed ID: 3096686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluvoxamine: an antidepressant for the elderly?
    Kellett JM
    J Psychiatry Neurosci; 1991 Jul; 16(2 Suppl 1):26-9. PubMed ID: 1931933
    [No Abstract]   [Full Text] [Related]  

  • 36. Influence of gender and menopausal status on antidepressant treatment response in depressed inpatients.
    Vermeiden M; van den Broek WW; Mulder PG; Birkenhäger TK
    J Psychopharmacol; 2010 Apr; 24(4):497-502. PubMed ID: 19423613
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CPT performance in major depressive disorder before and after treatment with imipramine or fluvoxamine.
    Koetsier GC; Volkers AC; Tulen JH; Passchier J; van den Broek WW; Bruijn JA
    J Psychiatr Res; 2002; 36(6):391-7. PubMed ID: 12393308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Double-blind comparative multicentre study of fluvoxamine and mianserin in the treatment of major depressive episode in elderly people.
    Phanjoo AL; Wonnacott S; Hodgson A
    Acta Psychiatr Scand; 1991 Jun; 83(6):476-9. PubMed ID: 1909083
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Paroxetine in major depression: a double-blind trial with imipramine and placebo.
    Cohn JB; Wilcox CS
    J Clin Psychiatry; 1992 Feb; 53 Suppl():52-6. PubMed ID: 1531826
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluvoxamine in the treatment of tricyclic-resistant depression.
    White K; Wykoff W; Tynes LL; Schneider L; Zemansky M
    Psychiatr J Univ Ott; 1990 Sep; 15(3):156-8. PubMed ID: 2123039
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.